FUSN - Fusion Pharmaceuticals  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $21.76. This is a potential upside of $0.21 (0.97%) from yesterday's end of day stock price of $21.55.

Fusion Pharmaceuticals 's activity chart (see below) currently has 32 price targets and 26 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 58.33% with an average time for these price targets to be met of 253 days.

Most recent stock forecast was given by YUAN ZHI from B. RILEY on 20-Mar-2024. First documented stock forecast 21-Jul-2020.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 20-Mar-2024

$13

$-8.55 (-39.68%)

$13

1 years 11 months 20 days ago
(20-Mar-2024)

3/4 (75%)

$-8.09 (-38.36%)

287

Hold Since 20-Mar-2024

$16

$-5.55 (-25.75%)

$16

1 years 11 months 20 days ago
(20-Mar-2024)

1/2 (50%)

$-5.09 (-24.13%)

15

Hold Since 19-Mar-2024

$11

$-10.55 (-48.96%)

$10

1 years 11 months 21 days ago
(19-Mar-2024)

1/2 (50%)

$-10.18 (-48.06%)

496

Buy Since 21-Jul-2020

$13

$-8.55 (-39.68%)

$13

2 years 1 months 14 days ago
(26-Jan-2024)

2/3 (66.67%)

$2.11 (19.38%)

131

Buy Since 23-Jun-2023

$16

$-5.55 (-25.75%)

$15

2 years 2 months 7 days ago
(05-Jan-2024)

4/4 (100%)

$7.65 (91.62%)

143

Show more analysts

Please expand the browser size to see the chart

What is FUSN (Fusion Pharmaceuticals ) average time for price targets to be met?

On average it took 253 days on average for the stock forecasts to be realized with a an average price target met ratio 58.33

Which analyst has the current highest performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?

MATTHEW HARRISON

Which analyst has the current lower performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?

GREGORY RENZA

Which analyst has the most public recommendations on FUSN (Fusion Pharmaceuticals )?

Matthew Harrison works at MORGAN STANLEY and has 8 price targets and 9 ratings on FUSN

Which analyst is the currently most bullish on FUSN (Fusion Pharmaceuticals )?

John Walsh with highest potential upside - $0

Which analyst is the currently most reserved on FUSN (Fusion Pharmaceuticals )?

Matthew Harrison with lowest potential downside - -$11.55

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?